Search

Suda raises $5.6m for drug development

Perth-based drug company Suda has raised $5.6 million to be used for its ArTiMist malaria treatment and other development products.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
293rdRefresh Group27%20%
409thOzgrowth7%5%
542ndAdvanced Braking Technology-14%-20%
638thSuda Pharmaceuticals-30%-16%
750thAvita Medical-51%-13%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

11/12/17
$0 Issued
11/12/17
$0 Issued
11/12/17
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

90th↑Avita Medical$8.0m
91st↓Advanced Braking Technology$7.7m
92nd↓Suda Pharmaceuticals$7.3m
93rd↑Ozgrowth$6.4m
94th↓Refresh Group$6.2m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Suda Pharmaceuticals

489thStephen J Carter$279k
494thJoseph Ohayon$277k
1117thMichael Stewart$79k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer